VYMRUN Trademark

Trademark Overview


On Tuesday, December 19, 2023, a trademark application was filed for VYMRUN with the United States Patent and Trademark Office. The USPTO has given the VYMRUN trademark a serial number of 98322364. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, October 25, 2024. This trademark is owned by Deciphera Pharmaceuticals, LLC. The VYMRUN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS);; Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors.
vymrun

General Information


Serial Number98322364
Word MarkVYMRUN
Filing DateTuesday, December 19, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS);; Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDeciphera Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2023NEW APPLICATION ENTERED
Thursday, March 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2024NON-FINAL ACTION WRITTEN
Thursday, July 18, 2024NON-FINAL ACTION E-MAILED
Thursday, July 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 18, 2024ASSIGNED TO EXAMINER
Tuesday, October 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 25, 2024SUSPENSION LETTER WRITTEN
Friday, October 25, 2024LETTER OF SUSPENSION E-MAILED